The ADAMTS19 gene helps make a protein that works outside cells to support and remodel connective tissue, including tissue in the heart valves. This gene plays an important role in keeping these structures working smoothly. If both copies do not work properly, some people can develop an inherited heart valve condition, often affecting the aortic valve, which may lead to valve narrowing or leakage. ADAMTS19 is mainly known in medical genetics rather than in popular culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ADAMTS19Gene function
What if the gene works
The ADAMTS19 gene helps make a protein that works outside cells. It supports the extracellular matrix, the network that gives tissues shape and strength.
Risk
What if the gene does not work
Biallelic variants in the ADAMTS19 gene are linked to inherited heart valve disease, especially affecting the aortic and mitral valves. Effects can range from milder changes found later in life to earlier, more marked valve thickening, leakage, or narrowing.
Treatment
What does that mean for your treatment
No ADAMTS19-specific treatment or management approach is currently established in clinical guidelines.
Gene function
What if the gene works
Your cells use the ADAMTS19 gene to make a protein that works mainly outside the cell. It helps manage the protein framework around cells, which gives tissues support and structure. In simple terms, this is part of what the ADAMTS19 gene does in the body every day.
The ADAMTS19 gene helps make an enzyme that cuts selected proteins outside cells. This careful trimming can reshape proteins or prepare them for removal, which helps keep the surrounding tissue framework organized.
Its protein contributes to the extracellular matrix (the supportive material around cells). This steady upkeep helps tissues hold their shape and supports normal contact between cells and their surroundings.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ADAMTS19 gene can change how much working protein is made and whether it folds, is released from the cell, or cuts its target molecules properly. More disruptive variants may create a shortened protein that is broken down early or never reaches the area outside the cell, while milder variants can leave some activity in place but reduce stability or binding. This range helps explain how ADAMTS19 gene variants affect function at different levels.
How variants are linked to conditions
The ADAMTS19 gene does not yet have a broadly confirmed link to a specific health condition, although research on ADAMTS19 gene conditions is still developing. If you have a reported variant in the ADAMTS19 gene, your doctor or genetic counselor can explain what that result means in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ADAMTS19 gene. Anyone with concerns about their personal or family risk can speak with a doctor or genetic counselor.
Inheritance of ADAMTS19 variants
There is not yet a broadly confirmed, single disease-specific inheritance pattern for the ADAMTS19 gene that is used consistently across clinical genetics, although this can become clearer as research grows. In practical terms, that means the answer to how ADAMTS19 gene variants are inherited is still being refined. The ADAMTS19 gene is located on chromosome 5, which is an autosome, so each person inherits one copy from each parent.
What does my ADAMTS19 result mean for my family?
For the recognized ADAMTS19-related heart valve condition, the family pattern is usually recessive. This means parents are often healthy carriers, brothers and sisters may also be affected or be carriers, and children are usually affected only if both parents carry a harmful ADAMTS19 change. Because of that, close relatives may want to review whether testing is relevant for them.
Genetic information
Genetic testing
How you find out about variants
ADAMTS19 genetic testing is how doctors look for changes in the ADAMTS19 gene, usually from a blood or saliva sample. A lab reads the gene’s DNA, often as part of a multigene panel, and the report classifies any variant as benign, uncertain, or pathogenic based on current evidence.
When should I consider getting a genetic test?
Genetic testing for the ADAMTS19 gene may be considered when there is a personal or family history of inherited heart valve disease, especially if it starts at a young age or affects several relatives. It can help show whether an ADAMTS19 change is part of the cause and whether other family members may benefit from evaluation.
A genetic result is only one part of your health story
Genetic findings can be informative, yet how much they reveal varies based on the condition and the specific type of variant. Over time, many other factors also shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, these results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, seem less helpful for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes shape the way medications affect a person. It focuses on gene-drug patterns to better explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can help support more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the ADAMTS19 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, treatment changes, or possible drug interactions are best discussed with your doctor or pharmacist.
History
ADAMTS19 entered the scientific literature in the early 2000s, when researchers were mapping and naming members of the ADAMTS gene family. Initially understood only through its similarity to related genes, it was added to a growing list of genes thought to help shape tissues during development. From these first observations, research expanded steadily as DNA sequencing made it easier to study rare inherited gene changes in affected families. Over time, descriptions became more precise, and ADAMTS19 was linked to specific human health conditions in case reports and genetic studies. Its history is mainly a modern research story rather than a public one, built through careful gene discovery, family studies, and improved sequencing technology.